Insider Transactions in Q3 2023 at Adaptimmune Therapeutics PLC (ADAP)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2023
|
Adrian Rawcliffe Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
2,403
-41.06%
|
$0
$0.78 P/Share
|
|
Aug 01
2023
|
John Lunger Chief Patient Supply Officer |
SELL
Open market or private sale
|
Direct |
3,096
-39.62%
|
$0
$0.91 P/Share
|
|
Jul 10
2023
|
Garry E Menzel Director |
SELL
Open market or private sale
|
Direct |
47,702
-38.86%
|
$0
$0.91 P/Share
|